Kevin Koch
Venture Partner @ OrbiMed
Boulder, United States
Kevin Koch is a Series A investor at OrbiMed in Boulder. Kevin Koch is based out of Boulder, Colorado and is the President and CEO of Edgewise Therapeutics. Kevin previously worked at Biogen as a Senior Vice President, Drug Discovery, Chemical & Molecular Therapeutics. Kevin Koch attended State University of New York, Stony Brook.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Stages Kevin Koch invests in
Countries Kevin Koch invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Stage
- Series A 1 (33%)
- Series B 1 (33%)
- Series C 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Terremoto Biosciences is a biotechnology company leveraging the power of lysine-based covalency to develop optimized medicines. | $108M / Series C / Apr 15, 2026 | ||
| Terremoto Biosciences is a biotechnology company leveraging the power of lysine-based covalency to develop optimized medicines. | $175M / Series B / Nov 02, 2023 | ||
| Terremoto Biosciences is a biotechnology company leveraging the power of lysine-based covalency to develop optimized medicines. | $75M / Series A / May 25, 2022 |
Co-Investors
About OrbiMed
OrbiMed executes multiple investment strategies, including private equity for startups, public equity for traded entities, and private credit for commercial-stage companies. It offers structured debt and royalty monetization as non-dilutive financing solutions for owners of intellectual property and medical diagnostics. The firm manages a global portfolio that supports the development of new therapies, medical devices, and healthcare information technology systems.
OrbiMed Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Dina Chaya
Partner
|
|||
|
Kevin Koch
Venture Partner
|
|||
Rishi Gupta
Private Equity Partner
|
|||
Sunny Sharma
Senior Managing Director
|
|||
Tadd S. Wessel
Managing Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
FAQ
How do I contact Kevin Koch?
Public channels for Kevin Koch include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Kevin Koch last invest?
The most recent investment recorded for Kevin Koch closed in Apr 2026. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
